Importance of Novel Intraperitoneal Therapy of NF-kappa B Inhibitor DHMEQImportance of Novel Intraperitoneal Therapy of NF-kappa B
Inhibitor DHMEQ
LEGG, L.A.,
TILNEY, R.,
HSIEH, C.F.,
WU, S.,
LUNDSTRÖM, E.,
RUDBERG, A.S.,
KUTLUBAEV, M.A.,
DENNIS, M.,
MEAD, G.E.,
SOLEIMANI, B.,
BARUGH, A.,
HACKETT, M.L.,
HANKEY, G.J (2019) Background: Stroke is a major cause of adult disability. Selective serotonin reuptake
inhibitorsYUE, E.,
TUGUZBAEVA, G.M.,
CHEN, X.,
LI, A.,
SUN, X.,
DONG, C.,
LIU, Y.,
YU, Y.,
ZAHRA, S.M.,
JIANG, Y.,
BAI, Y.,
QIN, Y.,
SHAN, Q.,
DU, Z. (2019) expression of NLRP3, caspase-1, and IL-1β. Upon administration of caspase-1
inhibitors, anthocyanin